Guest: Hyunjoon Kim, PhD

New mRNA therapeutics are on the horizon for patients with autoimmune diseases. What kind of impact might these therapeutics have? To answer this question, Dr. Hyunjoon Kim, Assistant Professor in the Department of Pharmaceutical Chemistry at the University of Kansas, joins us to explore these new therapeutics.